BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 18579078)

  • 1. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.
    Cheung KH; Shineman D; Müller M; Cárdenas C; Mei L; Yang J; Tomita T; Iwatsubo T; Lee VM; Foskett JK
    Neuron; 2008 Jun; 58(6):871-83. PubMed ID: 18579078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced ROS generation mediated by Alzheimer's disease presenilin regulation of InsP3R Ca2+ signaling.
    Müller M; Cheung KH; Foskett JK
    Antioxid Redox Signal; 2011 Apr; 14(7):1225-35. PubMed ID: 20701429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling.
    Müller M; Cárdenas C; Mei L; Cheung KH; Foskett JK
    Proc Natl Acad Sci U S A; 2011 Aug; 108(32):13293-8. PubMed ID: 21784978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of InsP3 receptor-mediated Ca2+ signaling alleviates mutant presenilin-linked familial Alzheimer's disease pathogenesis.
    Shilling D; Müller M; Takano H; Mak DO; Abel T; Coulter DA; Foskett JK
    J Neurosci; 2014 May; 34(20):6910-23. PubMed ID: 24828645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons.
    Cheung KH; Mei L; Mak DO; Hayashi I; Iwatsubo T; Kang DE; Foskett JK
    Sci Signal; 2010 Mar; 3(114):ra22. PubMed ID: 20332427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gain-of-function enhancement of IP3-receptor channel gating by familial Alzheimer's disease-linked presenilin mutants increases the open probability of mitochondrial permeability transition pore.
    Toglia P; Ullah G
    Cell Calcium; 2016 Jul; 60(1):13-24. PubMed ID: 27184076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing and Quantifying the Gain-of-Function Enhancement of IP3 Receptor Gating by Familial Alzheimer's Disease-Causing Mutants in Presenilins.
    Mak DO; Cheung KH; Toglia P; Foskett JK; Ullah G
    PLoS Comput Biol; 2015 Oct; 11(10):e1004529. PubMed ID: 26439382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired mitochondrial function due to familial Alzheimer's disease-causing presenilins mutants via Ca(2+) disruptions.
    Toglia P; Cheung KH; Mak DO; Ullah G
    Cell Calcium; 2016 May; 59(5):240-50. PubMed ID: 26971122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.
    Duncan RS; Song B; Koulen P
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol trisphosphate receptor Ca2+ release channels.
    Foskett JK; White C; Cheung KH; Mak DO
    Physiol Rev; 2007 Apr; 87(2):593-658. PubMed ID: 17429043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graded recruitment and inactivation of single InsP3 receptor Ca2+-release channels: implications for quantal [corrected] Ca2+release.
    Ionescu L; Cheung KH; Vais H; Mak DO; White C; Foskett JK
    J Physiol; 2006 Jun; 573(Pt 3):645-62. PubMed ID: 16644799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations.
    Tu H; Nelson O; Bezprozvanny A; Wang Z; Lee SF; Hao YH; Serneels L; De Strooper B; Yu G; Bezprozvanny I
    Cell; 2006 Sep; 126(5):981-93. PubMed ID: 16959576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous channel activity of the inositol 1,4,5-trisphosphate (InsP3) receptor (InsP3R). Application of allosteric modeling to calcium and InsP3 regulation of InsP3R single-channel gating.
    Mak DO; McBride SM; Foskett JK
    J Gen Physiol; 2003 Nov; 122(5):583-603. PubMed ID: 14581584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Alzheimer's disease mutations in presenilins: effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes.
    Nelson O; Supnet C; Liu H; Bezprozvanny I
    J Alzheimers Dis; 2010; 21(3):781-93. PubMed ID: 20634584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of the InsP₃ receptor type-1 and -2 single channel properties by InsP₃, Ca²⁺ and ATP.
    Wagner LE; Yule DI
    J Physiol; 2012 Jul; 590(14):3245-59. PubMed ID: 22547632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
    Zatti G; Burgo A; Giacomello M; Barbiero L; Ghidoni R; Sinigaglia G; Florean C; Bagnoli S; Binetti G; Sorbi S; Pizzo P; Fasolato C
    Cell Calcium; 2006 Jun; 39(6):539-50. PubMed ID: 16620965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological functions of presenilins; beyond γ-secretase.
    Stiller I; Lizák B; Bánhegyi G
    Curr Pharm Biotechnol; 2014; 15(11):1019-25. PubMed ID: 25420727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the Endoplasmic Reticulum (ER) Calcium Signaling Molecular Components in Alzheimer's Disease.
    Chami M; Checler F
    Cells; 2020 Dec; 9(12):. PubMed ID: 33271984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of calcium homeostasis in Alzheimer's disease.
    Small DH
    Neurochem Res; 2009 Oct; 34(10):1824-9. PubMed ID: 19337829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin-mediated signal transduction.
    Cowburn RF; Popescu BO; Ankarcrona M; Dehvari N; Cedazo-Minguez A
    Physiol Behav; 2007 Sep; 92(1-2):93-7. PubMed ID: 17568632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.